PRAME epitope (PRA300-309) Tumor-associated antigen
Cat.No:CLP0733 Solarbio
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
{{cart_num}}
My Cart>
Peptides >
Other Peptides >
PRAME epitope (PRA300-309) Tumor-associated antigenPurity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
Product Type | Peptides |
Sequence(1LC) | ALYVDSLFFL |
Sequence(3LC) | Ala-Leu-Tyr-Val-Asp-Ser-Leu-Phe-Phe-Leu |
Molecular Formula | C60H86N10O15 |
Molecular Weight | 1187.4 |
Purity | ≥95% |
Appearance | Lyophilized powder |
Salt Form | Trifluoroacetate salt |
Source | Synthetic |
Storage | Store at -20℃,2 years.(Avoid freeze/thaw cycles) |
Category/Label | Other Peptides |
Background | PRAME (Preferentially Expressed Antigen of Melanoma), first isolated as a human melanoma antigen recognized by cytotoxic T cells (CTL), is frequently expressed in a variety of cancers. The PRAME gene can be detected in some of the hematological malignancies, neuroblastomas and normal testis. PRAME is a promising marker for detection of minimal residual disease (MRD) in patients with leukemia and a particularly attractive target for immunotherapeutic strategies in neuroblastoma. |
In Vitro | undetected |
Reference | [1] Matsushita, M. et al. Leuk. Lymphoma 44, 439 (2003); [2] Kessler, J. et al. J. Exp. Med. 193, 73 (2001). |
Unit | Bottle |
Specification | 1mg 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.